加味生脉饮治疗冠心病的临床及实验研究
|
摘要
目的:收集病例进行临床观察,建立兔动脉粥样硬化模型进行实验研究,观察加味生脉饮治疗冠心病的临床疗效,并进一步探讨其抗动脉粥样硬化的作用机制。
方法:1.临床研究:将60例冠心病稳定型心绞痛患者随机分为2组,分别给予加味生脉饮+西药常规治疗(试验组)和西药常规治疗(对照组)治疗3个月。观察用药前后患者症状、体征及心电图的变化。2.实验研究:将24只新西兰大白兔,随机分为三组,每组8只,第一组为高脂组,饲以高胆固醇饮食(1%胆固醇+5%猪油的颗粒饲料);第二组作为中药组,用加味生脉饮(1g·d~(-1)·Kg~(-1)),同时饲以高胆固醇饮食(1%胆固醇+5%猪油的颗粒饲料);第三组为正常对照组,予正常饮食。三组均喂养4个月后,于耳缘静脉取血,采用酶学方法测定各组动物的血脂水平。处死动物,取胸主动脉,做HE染色、MASSON染色观察动脉硬化程度、斑块纤维含量,免疫组织化学染色观察平滑肌细胞的蛋白表达。
结果:1.临床研究:治疗后与对照组相比,试验组心绞痛病情积分显著降低(P<0.05),心绞痛疗效改善明显(P<0.05),中医症状积分明显降低(P<0.05),中医证候疗效显著改善(P<0.05),说明加味生脉饮能显著改善冠心病心绞痛患者的症状、体征。两组相比较,试验组心电图疗效(总有效率76.67%)改善优于对照组(总有效率43.33%)。治疗过程中,两组均未发现胃肠道不适、皮疹等不良反应。治疗前后肝、肾功能及三大常规检查亦无异常发现,说明使用该方法治疗是安全、可靠的。2.实验研究:(1)三组血脂结果比较:高胆固醇组、中药组的TC及LDL水平均明显高于正常饮食组(P<0.05),中药组的TC及LDL水平明显低于高胆固醇组(P<0.05),组间有统计学差异,加味生脉饮可降低血脂水平。(2)三组动脉粥样硬化程度比较:中药组血管内膜厚度、内膜/中膜厚度比值(I/M thickness)均较高脂组明显减小(P<0.05),斑块纤维含量明显升高(P<0.05)。(3)三组平滑肌细胞的蛋白表达:中药组与高胆固醇组相比,平滑肌细胞蛋白表达明显减少(P<0.05),而正常对照组无表达。
结论:1.加味生脉饮治疗冠心病稳定型心绞痛(气阴两虚证)疗效显著。2.加味生脉饮可以明显抑制动脉粥样硬化平滑肌细胞的蛋白表达。3.加味生脉饮可以明显减轻动脉粥样硬化的程度。
Objective:To study the clinical effect of Jia Wei Sheng Mai Yin (JWSMY) on the patients of coronary, and inquire into the mechanism of experimental atherosclerosis in Rabbits that its Resistance to atherosclerosis.
Methods:1.Clinical research:60 patiens of CHD with stable tired angina were chosen and divided into 2 groups randomly,one group were treated with anti-angina drugs and JWSMY as experiment group ,while the other group were treated with anti-angina drugs as control group.Three months later,we observed the effet on the patiens.2. Experimental Study: 24 New Zealand white rabbits were randomly divided into three groups, n = 8. The first group were fed a high cholesterol diet; the second group with JWSMY (1g·d~(-1)·Kg~(-1)), at the same time the rabbits were fed a high cholesterol diet; the third group to a normal diet. Three groups were fed four months later,we took some blood from the ear margin veins, and used enzymology methods to determine each animal blood lipid levels.Then we killed animals, took chest aortas, and made HE staing and MASSON staing to observe atherosclerosis and spot mass fiber.Also we used immunity organization chemistry to observe smooth muscle cells protein expression.
Results:1.Clinical research:Compared with control, the treatment group angina illness integral significantly reduced (P<0.05) after treatment,and the angina curative effect improved (P<0.05). TCM symptoms integral decreased obviously (P<0.05), and TCM symptoms improved efficacy significant (P<0.05). All of them could explain that JWSMY markedly improve CHD patients, angina symptoms, and signs. Two groups compared, the electrocardiogram curative effect of treatment group (the effective rate 76.67%)obviously improved than that in control group (the effective rate43.33 % ). In the course of treatment, both groups were not found fever, hemorrhage, skin rash, adverse reactions. During the treatment, the liver, kidney and three conventional check and also have no abnormal findings.This method treatment is safe and reliable. 2.Experimental research shows that: (1) Comparison of three groups of lipids:The degree of atherosclerosis was significantly lower in JWSMY group than that in high-cholesterol group.(2) Three degree of atherosclerosis in comparison:The intima thickness and intima-media thickness ratio (I/M thickness) of JWSMY group were significantly reduced than the high-cholesterol group (P< 0.05),and plaques fiber content increased obviously (P<0.05).(3)Three groups of smooth muscle cell protein expression: Compared with the high-cholesterol group,JWSMY group decreased significantly (P<0.05), and the normal control group without expression.
Conclusions:1.JWSMY treatment of coronary heart disease chronic stable angina (Qi and Yin deficiency syndrome) curative effect is distinct.2. JWSMY can significantly inhibited the protein expression of smooth muscle cells in AS. 3. JWSMY can significantly reduce the degree of atherosclerosis.
方法:1.临床研究:将60例冠心病稳定型心绞痛患者随机分为2组,分别给予加味生脉饮+西药常规治疗(试验组)和西药常规治疗(对照组)治疗3个月。观察用药前后患者症状、体征及心电图的变化。2.实验研究:将24只新西兰大白兔,随机分为三组,每组8只,第一组为高脂组,饲以高胆固醇饮食(1%胆固醇+5%猪油的颗粒饲料);第二组作为中药组,用加味生脉饮(1g·d~(-1)·Kg~(-1)),同时饲以高胆固醇饮食(1%胆固醇+5%猪油的颗粒饲料);第三组为正常对照组,予正常饮食。三组均喂养4个月后,于耳缘静脉取血,采用酶学方法测定各组动物的血脂水平。处死动物,取胸主动脉,做HE染色、MASSON染色观察动脉硬化程度、斑块纤维含量,免疫组织化学染色观察平滑肌细胞的蛋白表达。
结果:1.临床研究:治疗后与对照组相比,试验组心绞痛病情积分显著降低(P<0.05),心绞痛疗效改善明显(P<0.05),中医症状积分明显降低(P<0.05),中医证候疗效显著改善(P<0.05),说明加味生脉饮能显著改善冠心病心绞痛患者的症状、体征。两组相比较,试验组心电图疗效(总有效率76.67%)改善优于对照组(总有效率43.33%)。治疗过程中,两组均未发现胃肠道不适、皮疹等不良反应。治疗前后肝、肾功能及三大常规检查亦无异常发现,说明使用该方法治疗是安全、可靠的。2.实验研究:(1)三组血脂结果比较:高胆固醇组、中药组的TC及LDL水平均明显高于正常饮食组(P<0.05),中药组的TC及LDL水平明显低于高胆固醇组(P<0.05),组间有统计学差异,加味生脉饮可降低血脂水平。(2)三组动脉粥样硬化程度比较:中药组血管内膜厚度、内膜/中膜厚度比值(I/M thickness)均较高脂组明显减小(P<0.05),斑块纤维含量明显升高(P<0.05)。(3)三组平滑肌细胞的蛋白表达:中药组与高胆固醇组相比,平滑肌细胞蛋白表达明显减少(P<0.05),而正常对照组无表达。
结论:1.加味生脉饮治疗冠心病稳定型心绞痛(气阴两虚证)疗效显著。2.加味生脉饮可以明显抑制动脉粥样硬化平滑肌细胞的蛋白表达。3.加味生脉饮可以明显减轻动脉粥样硬化的程度。
Objective:To study the clinical effect of Jia Wei Sheng Mai Yin (JWSMY) on the patients of coronary, and inquire into the mechanism of experimental atherosclerosis in Rabbits that its Resistance to atherosclerosis.
Methods:1.Clinical research:60 patiens of CHD with stable tired angina were chosen and divided into 2 groups randomly,one group were treated with anti-angina drugs and JWSMY as experiment group ,while the other group were treated with anti-angina drugs as control group.Three months later,we observed the effet on the patiens.2. Experimental Study: 24 New Zealand white rabbits were randomly divided into three groups, n = 8. The first group were fed a high cholesterol diet; the second group with JWSMY (1g·d~(-1)·Kg~(-1)), at the same time the rabbits were fed a high cholesterol diet; the third group to a normal diet. Three groups were fed four months later,we took some blood from the ear margin veins, and used enzymology methods to determine each animal blood lipid levels.Then we killed animals, took chest aortas, and made HE staing and MASSON staing to observe atherosclerosis and spot mass fiber.Also we used immunity organization chemistry to observe smooth muscle cells protein expression.
Results:1.Clinical research:Compared with control, the treatment group angina illness integral significantly reduced (P<0.05) after treatment,and the angina curative effect improved (P<0.05). TCM symptoms integral decreased obviously (P<0.05), and TCM symptoms improved efficacy significant (P<0.05). All of them could explain that JWSMY markedly improve CHD patients, angina symptoms, and signs. Two groups compared, the electrocardiogram curative effect of treatment group (the effective rate 76.67%)obviously improved than that in control group (the effective rate43.33 % ). In the course of treatment, both groups were not found fever, hemorrhage, skin rash, adverse reactions. During the treatment, the liver, kidney and three conventional check and also have no abnormal findings.This method treatment is safe and reliable. 2.Experimental research shows that: (1) Comparison of three groups of lipids:The degree of atherosclerosis was significantly lower in JWSMY group than that in high-cholesterol group.(2) Three degree of atherosclerosis in comparison:The intima thickness and intima-media thickness ratio (I/M thickness) of JWSMY group were significantly reduced than the high-cholesterol group (P< 0.05),and plaques fiber content increased obviously (P<0.05).(3)Three groups of smooth muscle cell protein expression: Compared with the high-cholesterol group,JWSMY group decreased significantly (P<0.05), and the normal control group without expression.
Conclusions:1.JWSMY treatment of coronary heart disease chronic stable angina (Qi and Yin deficiency syndrome) curative effect is distinct.2. JWSMY can significantly inhibited the protein expression of smooth muscle cells in AS. 3. JWSMY can significantly reduce the degree of atherosclerosis.
引文
[1]陆再英,钟南山主编.内科学·第七版[M].人民卫生出版社,2008,267～268
[2]国际心脏病学会和协会及世界卫生组织临床命名标准化联合专题组.缺血性心脏病的命名及诊断标准[J].中华心血管病杂志,1981,9(1):75-76
[3]周仲瑛主编.中医内科学·2003年第1版[M].中国中医药出版社,2005,142～152
[4]吴圣贤,吴雪莲,黄政鑫,等.解毒软脉方抗动脉粥样硬化17例初步临床观察[J].福建中医药,2000,31(5):8-9
[5]石刚,刘婷,程丑夫.冠心病常见证候临床流行病学调查[J].中华中医药学刊,2007,25(8):1675
[6]卢秋霞.益气养阴活血方治疗冠心病心绞痛的临床观察[J].辽宁中医学院学报,2004,6(7):306-307
[7]卫蓉,李兰,邱兴磊,等.益气养阴活血法治疗冠心病心绞痛40例临床观察[J].贵阳中医学院学报,2O08,30(5):29-30
[8]高明.益气养阴法治疗冠心病54例观察[J].吉林中医药,2004,24(10):14
[9]周照丽,李芮,董波,等益心舒胶囊消退动脉硬化斑块的实验研究[J].中西医结合心脑血管病杂志,2009,7(10):1200
[10]李广浩,王佑华,周端.益气养阴、活血通阳法对动脉粥样硬化大鼠血脂的调节作用[J].中西医结合心脑血管病杂志,2009,7(6):676-677
[11]黄玫,曲晶,李晓天,等.黄芪化学成分及对心血管系统作用的研究进展[J].中国老年学杂志,2009,29(11):1451-1453
[12]邵南齐,朱萱萱.西洋参皂苷对心肌缺氧缺血的药理学研究进展[J].实用中医内科杂志,2007,21(3):3-4
[13]范宝晶,裴非,赵学忠,等.西洋参茎叶总皂苷对心肌肥厚大鼠血管内皮功能的影响[J].中国老年学杂志,2009,29(7):811-812
[14]包海花,袁晓环,韩雪山等.西洋参皂苷对H202致PCI2细胞损伤的保护作用[J].中国生化药物杂志,2009,30(5):302-305
[15]程金波,卫洪昌,章忱,等.麦冬提取物杭犬心肌缺血的药效学实验研究[J].中国病理生理杂志,2001,17(8) :810
[16]蒋凤荣,张旭,范俊,等.麦冬药理作用研究进展[J].中医药学刊,2006,24(2):236-237
[17]苏明威,王乃平,辛华雯,等.五味子药理作用研究进展[J].中国药师, 2009,12(7):960-962
[18]胡小戎,曹凤梅.丹参的药理、临床应用与制剂研究[J].中国新医药,2003,2(6):54-55
[19]王宏伟,张露,赵华月.川芎嚷对血管平滑肌细胞增殖及表达c-myc基因的影响[J].中国动脉硬化杂志,2000,8(4):319-321
[20]熊娟,潘勇军,郭桂香,等.川芎嗪对肥大心肌细胞中钙调神经磷酸酶信号转导通路的干预作用[J].医药导报,2009,28(10):1265-1268
[21]李文明,刘洪涛,李秀英,等.川芎嗪对脂多糖诱导的血管内皮细胞损伤的影响[J].中国药理学通报,2009,25(11):1516-1521
[22]刘竞天,李运曼,龚晓健,等.山楂酸对体外乳大鼠心肌细胞损伤的保护作用[J].中国新医药杂志,2008,17(9):743-747
[23]兰鸿,杜士明.山楂提取物防治高脂血症实验研究[J].中国现代药物应用,2009,3(24):3-5
[24]郝延军,桑育黎,赵余庆.决明子的研究进展[J].中草药, 2001,32 (9): 858 -859
[25]雷嘉川,余建清,廖志雄,等.决明子抗氧化作用的研究[J].中国中医药信息杂志,2006,13(11):41-42
[26] Charlotte Lawson, Sabine Wolf. ICAM-1 signaling in endothelial cells[J].Pharmacological Reports, 2009,61(1):22–32
[27]董秋立,胡圣,董波,等.氟伐他汀对兔动脉粥样硬化斑块炎症的影响[J].现代中西医结合杂志,2009,18(3):248-250
[28]嵇波,宋晓东,刘剑刚,等.氧化低密度脂蛋白诱导血管内皮细胞损伤的条件培养基对血管平滑肌细胞增殖的作用[J].中国分子心脏病学杂志,2004,4(5):279-283
[29]王东颖,林雪,廖瑜修主编.临床医学诊疗丛书·心血管内科分册[M].北京:华龄出版社,2008,118～126
[30] Rao GN, Berk BC. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression[J].Circ Res,1992, 70: 593-599
[31] Cheng Zhang, Yu Xia Zhao, Bo Dong,et al. Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells PNAS Early Edition[J].PNAS,2010,107 (36):15886-15891
[32]李琦,温进坤,郑斌.内皮和平滑肌相互作用与动脉粥样硬化发生机制的研究进展[J].生理科学进展,2003,34(1):27-31
[33]徐仓宝,张亚萍,李玉华内皮和平滑肌相互作用与动脉粥样硬化发生机制的研究进展[J].西安医科大学学报,1999,20(1):129-136
[34]任瑞军,葛志平,陈晓春.血管平滑肌细胞表型调节机制的研究进展[J].内蒙古医学杂志,2009,41(12):1469-1472
[35]李磊,戴敏.动脉粥样硬化血管内皮分泌功能失调与平滑肌细胞增殖[J].中国药理学通报,2010,26(2):155～158
[1]陆再英,钟南山主编.内科学·第七版[M].人民卫生出版社,2008,267～268
[2]周仲瑛主编.中医内科学·2003年第1版[M].中国中医药出版社,2005,143～144
[3]朱明,陆曙.动脉粥样硬化中医病机探析[J].陕西中医,2007,28(12):1655-1657
[4]韩景辉.动脉粥样硬化疾病的中医新认识[J].中医研究,2010,23(5):11-13
[5]许迎春,王化良,丁晶.动脉粥样硬化从毒论治探讨[J].中医杂志,2004,45 (6):405-407
[6]第五永长,肖颖,王友民.动脉粥样硬化中医病机探析[J].陕西中医学院学报,2003,26(6):8-9
[7]韩学杰,张立石,沈绍功等.痰瘀同治方对实验性动脉粥样硬化家兔主动脉、心肌及内皮细胞形态学的影响[J].中国动脉硬化杂志,2004,12(5):515-518
[8]刘宁,杨关林,姚福梅等.化痰祛瘀汤对动脉粥样硬化兔血管内皮功能的影响[J].实用中医内科杂志,2010,24(5):23-24
[9]胡怀强,周永红,曹秉振等.化浊行血丸治疗颈动脉粥样硬化症的临床研究[J].天津中医药大学学报, 2010,29(2): 66-68
[10]朱伟,潘宏,李志.痰瘀同治法对心肌缺血模型大鼠的作用及机制研究[J].陕西中医,2010,(31)2:237-238
[11]罗陆一,冯润芳.地黄饮子治疗颈动脉粥样硬化斑块的临床研究[J].中华医学研究杂志,2004,4(5):417.
[12]何航,沈晓君,冯黎.淫羊藿苷对动脉粥样硬化兔动脉内皮细胞损伤的保护作用[J].中医研究,2009,22(l2):15-17
[13]黑子清,吴伟康,孙惠兰等.四逆汤对家兔动脉粥样硬化的形成及血管壁神经酰胺含量的影响[J].中国病理生理杂志,2003,19(3):345-347
[14]庄小梅.活血化瘀方治疗原发性高血压及对血管内皮功能的影响.湖北中医杂志[J].2003,25(7):10
[15]张琪.血脉通颗粒对颈动脉粥样硬化的临床研究[J].南京中医药大学学报,2006,22(3):156
[16]周明学,徐浩,陈可冀等.活血解毒中药有效部位对ApoE基因敲除小鼠动脉粥样硬化斑块炎症反应的影响[J].中西医结合心脑血管病杂志,2007,5(12):l2O2—12O3
[17]林培政,杨开清.清热化湿消瘀法对湿热证模型兔肝脏清道夫受体基因表达的影响[J].中药新药与临床药理,2007,18(1):5
[18]马丽娟,王凤荣,郑娴等.加味大柴胡汤对动脉粥样硬化家兔主动脉细胞间黏附分子一1、核因子一κB表达的影响[J].安徽中医学院学报, 2009, 28(6): 46-50
[19]马彦玲,严建利,王秉岳等.化瘀泄浊汤对冠状动脉粥样硬化性心脏病心力衰竭hs—CRP、BNP水平及心功能的影响[J].河北中医,2009,3l(11):1620-1621
[20]龙华君,周珂,胡国恒等.清热化瘀颗粒对脑梗死伴颈动脉粥样硬化斑块的影响[J].中国中医急症,2010,19(6):908-933
[21]张艳,张洋,礼海等.益气活血复方对动脉粥样硬化家兔纤溶系统及TF的影响[J].中国医药指南,2009,7(21):34-35
[22]李慎贤,吴洪雷.化浊通脉散对家兔ASO模型血清及组织中TXB2、ET影响的实验研究[J].天津中医药,2010,27(4):3l5-317
[23]葛岚,程晓昱,胡业彬.益气活血解毒汤对实验性动脉粥样硬化家兔炎症细胞因子和血脂的影响[J].中国中西医结合急救杂志,2007,14(5):306
[24]金潇,朱陵群,庞鹤.益气活血解毒法对氧化低密度脂蛋白诱导内皮细胞黏附作用的影响[J].北京中医药,2010,29(8):631-634
[25]田广周,路世亮.温养软脉方用于治疗颈动脉粥样硬化患者的研究分析[J].中国实用医药,2010,5(19):146-147
[26]张忠,黄若兰,徐慕娟等.加味抵当汤干预颈动脉粥样硬化易损斑块的临床研究[J].中医药通报,2010,9(3):42-45
[27]贾运乔,侯桂英,司秋菊等.大黄庶虫丸对大鼠动脉粥样硬化斑块及CD40表达的影响[J].河北中医,2010,32(3):426-463
[28]赵学军,李任先,刘国普等.理脾化痰方对食饵性动脉粥样硬化症家兔血管平滑肌细胞增殖和凋亡的调控[J].广州中医药大学学报,2001,18(2):144—148
[29]王燕燕.丹参注射液治疗冠心病心绞痛的临床观察[J].中国中西医结合急救杂志,2002,9(5):307-308
[30]唐忠志,付立波.丹参注射液对冠心病患者血浆内皮素和一氧化氮水平的影响[J].华南国防医学杂志,2OO5,19(2):48-49
[31]刘海陵,扈友庄,杨彬等.丹参注射液对不稳定型心绞痛患者血清sICAM-1的影响[J].2004,23(11):807-809
[32]张梅,温进坤,孙辉臣等.丹参注射液对动脉粥样硬化大鼠血脂及细胞间粘附分子一1表达的影响[J].中国病理生理杂志,2004,20(10):1871-1873
[33]王振涛,韩丽华,朱明军等.川芎嗪注射液促心梗后大鼠缺血心肌血管新生作用及对相关生长因子影晌的研究[J].辽宁中医杂志,2006,33(7):889-890
[34]陈旭,胡春杰,陈日等.川芎嗪注射液治疗冠心病心绞痛的实验研究[J].吉林中医药,2007,27(11):53-54
[35]尹刚,张鹏.川芎嗪注射液治疗不稳定型心绞痛疗效观察[J].山东中医杂志,2007,26(11):762-764
[36]程霞.川芎嗪注射液对颈动脉粥样硬化斑块消退的临床观察[J].中西医结合心脑血管病杂志,2010,8(7):781-782
[37]曾小楠,樊光辉,陈宏等.葛根素对陈旧性心肌梗死患者血浆心钠素和超氧化物歧化酶的影响[J].心血管病杂志,2000,16(10):470—47l.
[38]王军,孙冠军,倪子琴.葛根素注射液治疗冠心病心绞痛60例分析[J].哈尔滨医药,2009,29(2):20-21
[39]裴丽光.参脉注射液治疗不稳定型心绞痛临床观察[J].现代中西医结合杂志,2009,18(3):256-271
[40]施志琴,宋垣,张汉新.参麦注射液和丹参注射液治疗冠心病106例临床疗效观察[J].浙江中医学院学报,2005,29(2):30-31
[41]蒋文彬,金小桦,朱明真等.血栓通治疗冠心病7O例疗效观察[J].中国交通医学杂志,2005,19(1):21
[42]刘晓优.生脉注射液治疗冠心病患者135例疗效观察[J].实用医技杂志, 2006,13(15):2663-2664
[43]田成海,刘爱东,隋殿军.生脉注射液治疗冠心病心绞痛气阴两虚型71例[J].长春中医药大学学报, 2008,24(1):63
[44]杨娟,何迎春,许羚等.注射用红花黄色素治疗稳定型劳累性心绞痛疗效的系统评价[J].中国临床药理学和治疗学,2008,13(9):1029-1036
[45]王小艳,韩晓云,连亚军等.心肌做功指数评价注射用红花黄色素对冠心病患者心功能的影响[J].山西医药杂志,2010,39(6):535-537
[46]杨松波.红花色素治疗稳定型劳累性心绞痛21例疗效观察[J].内蒙古中医药,2010,29(3):19
[2]国际心脏病学会和协会及世界卫生组织临床命名标准化联合专题组.缺血性心脏病的命名及诊断标准[J].中华心血管病杂志,1981,9(1):75-76
[3]周仲瑛主编.中医内科学·2003年第1版[M].中国中医药出版社,2005,142～152
[4]吴圣贤,吴雪莲,黄政鑫,等.解毒软脉方抗动脉粥样硬化17例初步临床观察[J].福建中医药,2000,31(5):8-9
[5]石刚,刘婷,程丑夫.冠心病常见证候临床流行病学调查[J].中华中医药学刊,2007,25(8):1675
[6]卢秋霞.益气养阴活血方治疗冠心病心绞痛的临床观察[J].辽宁中医学院学报,2004,6(7):306-307
[7]卫蓉,李兰,邱兴磊,等.益气养阴活血法治疗冠心病心绞痛40例临床观察[J].贵阳中医学院学报,2O08,30(5):29-30
[8]高明.益气养阴法治疗冠心病54例观察[J].吉林中医药,2004,24(10):14
[9]周照丽,李芮,董波,等益心舒胶囊消退动脉硬化斑块的实验研究[J].中西医结合心脑血管病杂志,2009,7(10):1200
[10]李广浩,王佑华,周端.益气养阴、活血通阳法对动脉粥样硬化大鼠血脂的调节作用[J].中西医结合心脑血管病杂志,2009,7(6):676-677
[11]黄玫,曲晶,李晓天,等.黄芪化学成分及对心血管系统作用的研究进展[J].中国老年学杂志,2009,29(11):1451-1453
[12]邵南齐,朱萱萱.西洋参皂苷对心肌缺氧缺血的药理学研究进展[J].实用中医内科杂志,2007,21(3):3-4
[13]范宝晶,裴非,赵学忠,等.西洋参茎叶总皂苷对心肌肥厚大鼠血管内皮功能的影响[J].中国老年学杂志,2009,29(7):811-812
[14]包海花,袁晓环,韩雪山等.西洋参皂苷对H202致PCI2细胞损伤的保护作用[J].中国生化药物杂志,2009,30(5):302-305
[15]程金波,卫洪昌,章忱,等.麦冬提取物杭犬心肌缺血的药效学实验研究[J].中国病理生理杂志,2001,17(8) :810
[16]蒋凤荣,张旭,范俊,等.麦冬药理作用研究进展[J].中医药学刊,2006,24(2):236-237
[17]苏明威,王乃平,辛华雯,等.五味子药理作用研究进展[J].中国药师, 2009,12(7):960-962
[18]胡小戎,曹凤梅.丹参的药理、临床应用与制剂研究[J].中国新医药,2003,2(6):54-55
[19]王宏伟,张露,赵华月.川芎嚷对血管平滑肌细胞增殖及表达c-myc基因的影响[J].中国动脉硬化杂志,2000,8(4):319-321
[20]熊娟,潘勇军,郭桂香,等.川芎嗪对肥大心肌细胞中钙调神经磷酸酶信号转导通路的干预作用[J].医药导报,2009,28(10):1265-1268
[21]李文明,刘洪涛,李秀英,等.川芎嗪对脂多糖诱导的血管内皮细胞损伤的影响[J].中国药理学通报,2009,25(11):1516-1521
[22]刘竞天,李运曼,龚晓健,等.山楂酸对体外乳大鼠心肌细胞损伤的保护作用[J].中国新医药杂志,2008,17(9):743-747
[23]兰鸿,杜士明.山楂提取物防治高脂血症实验研究[J].中国现代药物应用,2009,3(24):3-5
[24]郝延军,桑育黎,赵余庆.决明子的研究进展[J].中草药, 2001,32 (9): 858 -859
[25]雷嘉川,余建清,廖志雄,等.决明子抗氧化作用的研究[J].中国中医药信息杂志,2006,13(11):41-42
[26] Charlotte Lawson, Sabine Wolf. ICAM-1 signaling in endothelial cells[J].Pharmacological Reports, 2009,61(1):22–32
[27]董秋立,胡圣,董波,等.氟伐他汀对兔动脉粥样硬化斑块炎症的影响[J].现代中西医结合杂志,2009,18(3):248-250
[28]嵇波,宋晓东,刘剑刚,等.氧化低密度脂蛋白诱导血管内皮细胞损伤的条件培养基对血管平滑肌细胞增殖的作用[J].中国分子心脏病学杂志,2004,4(5):279-283
[29]王东颖,林雪,廖瑜修主编.临床医学诊疗丛书·心血管内科分册[M].北京:华龄出版社,2008,118～126
[30] Rao GN, Berk BC. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression[J].Circ Res,1992, 70: 593-599
[31] Cheng Zhang, Yu Xia Zhao, Bo Dong,et al. Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells PNAS Early Edition[J].PNAS,2010,107 (36):15886-15891
[32]李琦,温进坤,郑斌.内皮和平滑肌相互作用与动脉粥样硬化发生机制的研究进展[J].生理科学进展,2003,34(1):27-31
[33]徐仓宝,张亚萍,李玉华内皮和平滑肌相互作用与动脉粥样硬化发生机制的研究进展[J].西安医科大学学报,1999,20(1):129-136
[34]任瑞军,葛志平,陈晓春.血管平滑肌细胞表型调节机制的研究进展[J].内蒙古医学杂志,2009,41(12):1469-1472
[35]李磊,戴敏.动脉粥样硬化血管内皮分泌功能失调与平滑肌细胞增殖[J].中国药理学通报,2010,26(2):155～158
[1]陆再英,钟南山主编.内科学·第七版[M].人民卫生出版社,2008,267～268
[2]周仲瑛主编.中医内科学·2003年第1版[M].中国中医药出版社,2005,143～144
[3]朱明,陆曙.动脉粥样硬化中医病机探析[J].陕西中医,2007,28(12):1655-1657
[4]韩景辉.动脉粥样硬化疾病的中医新认识[J].中医研究,2010,23(5):11-13
[5]许迎春,王化良,丁晶.动脉粥样硬化从毒论治探讨[J].中医杂志,2004,45 (6):405-407
[6]第五永长,肖颖,王友民.动脉粥样硬化中医病机探析[J].陕西中医学院学报,2003,26(6):8-9
[7]韩学杰,张立石,沈绍功等.痰瘀同治方对实验性动脉粥样硬化家兔主动脉、心肌及内皮细胞形态学的影响[J].中国动脉硬化杂志,2004,12(5):515-518
[8]刘宁,杨关林,姚福梅等.化痰祛瘀汤对动脉粥样硬化兔血管内皮功能的影响[J].实用中医内科杂志,2010,24(5):23-24
[9]胡怀强,周永红,曹秉振等.化浊行血丸治疗颈动脉粥样硬化症的临床研究[J].天津中医药大学学报, 2010,29(2): 66-68
[10]朱伟,潘宏,李志.痰瘀同治法对心肌缺血模型大鼠的作用及机制研究[J].陕西中医,2010,(31)2:237-238
[11]罗陆一,冯润芳.地黄饮子治疗颈动脉粥样硬化斑块的临床研究[J].中华医学研究杂志,2004,4(5):417.
[12]何航,沈晓君,冯黎.淫羊藿苷对动脉粥样硬化兔动脉内皮细胞损伤的保护作用[J].中医研究,2009,22(l2):15-17
[13]黑子清,吴伟康,孙惠兰等.四逆汤对家兔动脉粥样硬化的形成及血管壁神经酰胺含量的影响[J].中国病理生理杂志,2003,19(3):345-347
[14]庄小梅.活血化瘀方治疗原发性高血压及对血管内皮功能的影响.湖北中医杂志[J].2003,25(7):10
[15]张琪.血脉通颗粒对颈动脉粥样硬化的临床研究[J].南京中医药大学学报,2006,22(3):156
[16]周明学,徐浩,陈可冀等.活血解毒中药有效部位对ApoE基因敲除小鼠动脉粥样硬化斑块炎症反应的影响[J].中西医结合心脑血管病杂志,2007,5(12):l2O2—12O3
[17]林培政,杨开清.清热化湿消瘀法对湿热证模型兔肝脏清道夫受体基因表达的影响[J].中药新药与临床药理,2007,18(1):5
[18]马丽娟,王凤荣,郑娴等.加味大柴胡汤对动脉粥样硬化家兔主动脉细胞间黏附分子一1、核因子一κB表达的影响[J].安徽中医学院学报, 2009, 28(6): 46-50
[19]马彦玲,严建利,王秉岳等.化瘀泄浊汤对冠状动脉粥样硬化性心脏病心力衰竭hs—CRP、BNP水平及心功能的影响[J].河北中医,2009,3l(11):1620-1621
[20]龙华君,周珂,胡国恒等.清热化瘀颗粒对脑梗死伴颈动脉粥样硬化斑块的影响[J].中国中医急症,2010,19(6):908-933
[21]张艳,张洋,礼海等.益气活血复方对动脉粥样硬化家兔纤溶系统及TF的影响[J].中国医药指南,2009,7(21):34-35
[22]李慎贤,吴洪雷.化浊通脉散对家兔ASO模型血清及组织中TXB2、ET影响的实验研究[J].天津中医药,2010,27(4):3l5-317
[23]葛岚,程晓昱,胡业彬.益气活血解毒汤对实验性动脉粥样硬化家兔炎症细胞因子和血脂的影响[J].中国中西医结合急救杂志,2007,14(5):306
[24]金潇,朱陵群,庞鹤.益气活血解毒法对氧化低密度脂蛋白诱导内皮细胞黏附作用的影响[J].北京中医药,2010,29(8):631-634
[25]田广周,路世亮.温养软脉方用于治疗颈动脉粥样硬化患者的研究分析[J].中国实用医药,2010,5(19):146-147
[26]张忠,黄若兰,徐慕娟等.加味抵当汤干预颈动脉粥样硬化易损斑块的临床研究[J].中医药通报,2010,9(3):42-45
[27]贾运乔,侯桂英,司秋菊等.大黄庶虫丸对大鼠动脉粥样硬化斑块及CD40表达的影响[J].河北中医,2010,32(3):426-463
[28]赵学军,李任先,刘国普等.理脾化痰方对食饵性动脉粥样硬化症家兔血管平滑肌细胞增殖和凋亡的调控[J].广州中医药大学学报,2001,18(2):144—148
[29]王燕燕.丹参注射液治疗冠心病心绞痛的临床观察[J].中国中西医结合急救杂志,2002,9(5):307-308
[30]唐忠志,付立波.丹参注射液对冠心病患者血浆内皮素和一氧化氮水平的影响[J].华南国防医学杂志,2OO5,19(2):48-49
[31]刘海陵,扈友庄,杨彬等.丹参注射液对不稳定型心绞痛患者血清sICAM-1的影响[J].2004,23(11):807-809
[32]张梅,温进坤,孙辉臣等.丹参注射液对动脉粥样硬化大鼠血脂及细胞间粘附分子一1表达的影响[J].中国病理生理杂志,2004,20(10):1871-1873
[33]王振涛,韩丽华,朱明军等.川芎嗪注射液促心梗后大鼠缺血心肌血管新生作用及对相关生长因子影晌的研究[J].辽宁中医杂志,2006,33(7):889-890
[34]陈旭,胡春杰,陈日等.川芎嗪注射液治疗冠心病心绞痛的实验研究[J].吉林中医药,2007,27(11):53-54
[35]尹刚,张鹏.川芎嗪注射液治疗不稳定型心绞痛疗效观察[J].山东中医杂志,2007,26(11):762-764
[36]程霞.川芎嗪注射液对颈动脉粥样硬化斑块消退的临床观察[J].中西医结合心脑血管病杂志,2010,8(7):781-782
[37]曾小楠,樊光辉,陈宏等.葛根素对陈旧性心肌梗死患者血浆心钠素和超氧化物歧化酶的影响[J].心血管病杂志,2000,16(10):470—47l.
[38]王军,孙冠军,倪子琴.葛根素注射液治疗冠心病心绞痛60例分析[J].哈尔滨医药,2009,29(2):20-21
[39]裴丽光.参脉注射液治疗不稳定型心绞痛临床观察[J].现代中西医结合杂志,2009,18(3):256-271
[40]施志琴,宋垣,张汉新.参麦注射液和丹参注射液治疗冠心病106例临床疗效观察[J].浙江中医学院学报,2005,29(2):30-31
[41]蒋文彬,金小桦,朱明真等.血栓通治疗冠心病7O例疗效观察[J].中国交通医学杂志,2005,19(1):21
[42]刘晓优.生脉注射液治疗冠心病患者135例疗效观察[J].实用医技杂志, 2006,13(15):2663-2664
[43]田成海,刘爱东,隋殿军.生脉注射液治疗冠心病心绞痛气阴两虚型71例[J].长春中医药大学学报, 2008,24(1):63
[44]杨娟,何迎春,许羚等.注射用红花黄色素治疗稳定型劳累性心绞痛疗效的系统评价[J].中国临床药理学和治疗学,2008,13(9):1029-1036
[45]王小艳,韩晓云,连亚军等.心肌做功指数评价注射用红花黄色素对冠心病患者心功能的影响[J].山西医药杂志,2010,39(6):535-537
[46]杨松波.红花色素治疗稳定型劳累性心绞痛21例疗效观察[J].内蒙古中医药,2010,29(3):19